Ambryon Biosciences

In vivo genome editing using Staphylococcus aureus Cas9

Ran et al. (2015). NatureResearch

SpCas9's size limited AAV packaging for in vivo editing, and alternatives like St1Cas9 had drawbacks. This paper found S. aureus Cas9 (SaCas9), over 1 kb shorter than SpCas9, matching its efficiency. AAV8-delivered SaCas9 targeting Pcsk9 cut serum Pcsk9 by 95% in mice.

Identifiers & revision